The soluble form of Fas (sFas) can block apoptosis induced by the Fas ligand in vitro. A recent report demonstrated that mice injected with sFas displayed autoimmune features. Therefore, an elevated serum concentration of sFas may be associated with lymphoproliferation and autoimmune diseases. We me
Serum-soluble Fas level determines clinical symptoms and outcome of patients with aggressive non-Hodgkin's lymphoma
โ Scribed by Takeshi Hara; Hisashi Tsurumi; Masao Takemura; Hideko Goto; Toshiki Yamada; Michio Sawada; Takeshi Takahashi; Hisataka Moriwaki
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- English
- Weight
- 75 KB
- Volume
- 64
- Category
- Article
- ISSN
- 0361-8609
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
W e read with interest the article published in Cancer earlier this year regarding the elevation of CA 125 in patients with non-Hodgkin's lymphoma and its normalization with clinical response. 1 Earlier a case report had also emerged about elevation of CA 125 in a patient within tuberculous peritoni
## Background: Ca 125 is a glycoprotein produced by epithelial ovarian tumors and by mesothelial cells; its levels also have been shown to be elevated in patients with non-hodgkin's lymphoma (nhl). ## Methods: The authors evaluated serum ca 125 levels in patients with nhl to elucidate the frequen